Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 2
1993 4
1994 2
1996 5
1997 3
1998 2
1999 3
2000 3
2002 3
2003 3
2004 2
2005 6
2006 1
2007 7
2008 1
2009 5
2010 8
2011 13
2012 14
2013 13
2014 16
2015 20
2016 22
2017 25
2018 15
2019 19
2020 24
2021 30
2022 12
2023 18
2024 11
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Roberts JA, et al. Among authors: vinks aa. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Lancet Infect Dis. 2014. PMID: 24768475 Free PMC article. Review.
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey LB, Balis FM, O'Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A, Schwartz S, Vinks AA, Heldrup J. Ramsey LB, et al. Among authors: vinks aa. Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27. Oncologist. 2018. PMID: 29079637 Free PMC article.
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Bergan S, et al. Among authors: vinks aa. Ther Drug Monit. 2021 Apr 1;43(2):150-200. doi: 10.1097/FTD.0000000000000871. Ther Drug Monit. 2021. PMID: 33711005 Review.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.
Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik R, Thummel KE, Klein TE, Caudle KE, MacPhee IA. Birdwell KA, et al. Among authors: vinks aa. Clin Pharmacol Ther. 2015 Jul;98(1):19-24. doi: 10.1002/cpt.113. Epub 2015 Jun 3. Clin Pharmacol Ther. 2015. PMID: 25801146 Free PMC article.
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
Adams DM, Trenor CC 3rd, Hammill AM, Vinks AA, Patel MN, Chaudry G, Wentzel MS, Mobberley-Schuman PS, Campbell LM, Brookbank C, Gupta A, Chute C, Eile J, McKenna J, Merrow AC, Fei L, Hornung L, Seid M, Dasgupta AR, Dickie BH, Elluru RG, Lucky AW, Weiss B, Azizkhan RG. Adams DM, et al. Among authors: vinks aa. Pediatrics. 2016 Feb;137(2):e20153257. doi: 10.1542/peds.2015-3257. Epub 2016 Jan 18. Pediatrics. 2016. PMID: 26783326 Free PMC article. Clinical Trial.
Precision Dosing: The Clinical Pharmacology of Goldilocks.
Peck RW, Shahin MH, Vinks AA. Peck RW, et al. Among authors: vinks aa. Clin Pharmacol Ther. 2021 Jan;109(1):11-14. doi: 10.1002/cpt.2112. Clin Pharmacol Ther. 2021. PMID: 33616906 Review. No abstract available.
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.
Weiss BD, Wolters PL, Plotkin SR, Widemann BC, Tonsgard JH, Blakeley J, Allen JC, Schorry E, Korf B, Robison NJ, Goldman S, Vinks AA, Emoto C, Fukuda T, Robinson CT, Cutter G, Edwards L, Dombi E, Ratner N, Packer R, Fisher MJ. Weiss BD, et al. Among authors: vinks aa. J Clin Oncol. 2021 Mar 1;39(7):797-806. doi: 10.1200/JCO.20.02220. Epub 2021 Jan 28. J Clin Oncol. 2021. PMID: 33507822 Free PMC article. Clinical Trial.
Novel Therapeutic Modalities: The Future is Now.
Choi Y, Vinks AA, van der Graaf PH. Choi Y, et al. Among authors: vinks aa. Clin Pharmacol Ther. 2023 Sep;114(3):493-496. doi: 10.1002/cpt.2996. Clin Pharmacol Ther. 2023. PMID: 37594205 No abstract available.
Precision Medicine-Nobody Is Average.
Vinks AA. Vinks AA. Clin Pharmacol Ther. 2017 Mar;101(3):304-307. doi: 10.1002/cpt.600. Clin Pharmacol Ther. 2017. PMID: 28194769
265 results